ALPS ETF TR - MED BREAKTHGH (SBIO)

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / MED BREAKTHGH
Total 13F shares
1,485,532
Share change
+50,602
Total reported value
$49,104,003
Put/Call ratio
20%
Price per share
$33.03
Number of holders
35
Value change
+$1,992,411
Number of buys
17
Number of sells
14

Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q4 2024

As of 31 Dec 2024, ALPS ETF TR - MED BREAKTHGH (SBIO) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,485,532 shares. The largest 10 holders included DAVENPORT & Co LLC, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, UBS Group AG, GTS SECURITIES LLC, GRIFFIN ASSET MANAGEMENT, INC., NTV Asset Management LLC, LPL Financial LLC, and Phoenix Wealth Advisors. This page lists 35 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.